DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20164554

Association of non-alcoholic fatty liver disease with anthropometric and metabolic parameters in type 2 diabetes: a retrospective analysis

Shiraz S. Khan, Nishad S. Kannu, Sagar S. Patil, Vijay M. Katekhaye

Abstract


Background: Type 2 diabetes (T2D) is associated with increased prevalence of non-alcoholic fatty liver disease (NAFLD) which mediates increased insulin resistance and is associated with cardiovascular disease (CVD) risk factors. Aim of the study was to understand the association of NAFLD with anthropometric and metabolic parameters in T2DM.

Methods: A retrospective observation of data obtained from a private diabetes care centre in non-alcoholic T2D patients was performed. Association of presence of NAFLD with anthropometric, metabolic (glycemic, lipid) parameters, and also blood pressure were assessed. Patients were duly informed that the data collected pertaining to their illness could be used for research purposes. No changes or interventions in the management of the illness were made as part of this study.

Results: In total, 300 cases were included in analysis. NAFLD was seen in 38.0% of the cases. Patients with fatty liver were much older than those without fatty liver (P<0.0001). A significant association of NAFLD was seen with all anthropometric (P<0.05 for each) and lipid (p<0.05 for each) parameters and also systolic and diastolic blood pressure measurements (p<0.0001 for both). There was no significant association with glycemic levels in patients with NAFLD. Other factors which had significant association with fatty liver include duration of diabetes, duration of hypertension and a known history of hypertension and dyslipidaemia (p<0.0001 for each).

Conclusions: NAFLD has significant association with cardio-metabolic risk factors and may be an independent risk factor for CV disease. Further prospective studies with effect of diabetes treatment and progression/regression of NAFLD and its association with CV outcomes in T2D are warranted.

Keywords


Blood pressure, BMI, Lipids, NAFLD, Type 2 Diabetes, Weight

Full Text:

PDF

References


Bellentani S, Marino M. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann Hepatol. 2009;8(1):s4-8.

IDF Diabetes Atlas 7th Edition, 2015. International Diabetes Federation. 2015. Available from http://www.diabetesatlas.org/ resources/ 2015-atlas.html Accessed on 02 October 2016.

Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond). 2008;115(5):141-50.

Kalra S, Vithalani M, Gulati G, Kulkarni CM, Kadam Y, Pallivathukkal J, et al. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). J Assoc Physicians India. 2013;61(7):448-53.

Roden M. Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab. 2006;2(6):335-48.

Harris EH. Elevated Liver Function Tests in Type 2 Diabetes. Clin Diabetes. 2005;23(3):115-9.

Liu H, Lu HY. Non-alcoholic fatty liver disease and cardiovascular disease. World J Gastroenterol. 2014; 20(26):8407-15.

Singh D, Das CJ, Baruah MP. Imaging of non-alcoholic fatty liver disease: A road less travelled. Indian J Endocrinol Metab. 2013;17(6):990-5.

Sharavanan TKV, Premalatha E. Prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus patients in a rural health care hospital. Sch. J. App. Med. Sci. 2015; 3(5A):1834-7.

Majumdar A, Misra P, Sharma S, Kant S, Krishnan A, Pandav CS. Prevalence of nonalcoholic fatty liver disease in an adult population in a rural community of Haryana, India. Indian J Public Health. ndian J Public Health. 2016;60(1):26-33.

Nagaraj S, Kiran SS, Gandham R, WDSC R, Nagaraja MR, AN S, et al. Study of prevalence of non alcoholic fatty liver disease in type 2 diabetes mellitus patients and variations in liver function tests , lipid profile and mean platelet volume in patients with fatty liver in comparison with patients without fatty liver. Int J Res Med Sci. 2016;4(3):871-6.

Rao SV, Sikariya KK. Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus in a Tertiary Care Centre In Western India. IOSR J Dental Med Sci. 2016;15(2):1-7.

Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis. 2007;191(2):235-40.

Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract. 2009;84(1):84-91.

Agarwal AK, Jain V, Singla S, Baruah BP, Arya V, Yadav R, et al. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes 2671. J AssocPhysicians India. 2011;59:351-4.

Ferreira VSG, Pernambuco RB, Lopes EP, Morais CN, Rodrigues MC, Arruda MJ, et al. Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Arq Bras Endocrinol Metabol. 2010;54(4):362-8.

Ortiz-Lopez C, Lomonaco R, Orsak B, Finch J, Chang Z, Kochunov VG, et al. Prevalence of prediabetes and diabetes and metabolic profile of patients with Nonalcoholic Fatty Liver Disease (NAFLD). Diabetes Care. 2012;35(4):873-8.

Pai S, M C, Madi DR, Achappa B, Unnikrishnan. Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Int J Biol Med Res. 2012;3(3):2189-92.

Somalwar A, Raut A. Study of association of non-alcoholic fatty liver disease (NAFLD) with micro and macrovascular complications of type 2 diabetes mellitus (T2DM). Int J Res Med Sci. 2014;2(2):493-7.

Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, et al. Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2. Diabetes Care. 2007;30(5):1212-8.

Kwok R, Choi KC, Wong GL-H, Zhang Y, Chan HL-Y, Luk a. O-Y, et al. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. Gut. 2015;1-10.

Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. Q J Med. 2010;103(2):71-83.

Ryoo J, Suh YJ, Shin HC, Cho YK, Choi J. Clinical association between non-alcoholic fatty liver disease and the development of hypertension. J Gastroenterol Hepatol. 2014;29(11):1926-31.

Latea L, Negrea S, Bolboaca S. Primary non-alcoholic fatty liver disease in hypertensive patients. Australas Med J. 2013;6(6):325-30.

Fruci B, Giuliano S, Mazza A, Malaguarnera R, Belfiore A. Nonalcoholic fatty liver: A possible new target for type 2 diabetes prevention and treatment. International Journal of Molecular Sciences. 2013;14:22933-66.